The following table provides an overview of the latest patents of Santen Pharmaceutical Co., Ltd. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3463360Aug 31, 2022Atropine-Containing Aqueous Composition2
EP3714877Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
EP3205334Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
EP2772249May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1